U.S. Neurovascular Intervention Devices Market Size Worth USD 2.46 Billion by 2034 | CAGR: 4.3%

The U.S. Neurovascular Intervention Devices Market size is expected to reach USD 2.46 Billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Neurovascular Intervention Devices Market Share, Size, Trends, Industry Analysis Report: By Product, By Technique, and By End User; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for neurovascular intervention devices in the U.S. is growing due to their extensive use in treating ischemic stroke, intracranial aneurysms, and other cerebrovascular disorders. These devices includes stents, coils, thrombectomy systems, flow diverters, and embolic protection devices to support minimally invasive surgery, faster patient recovery and improved procedural outcomes.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-neurovascular-intervention-devices-market/request-for-sample

Market growth is driven by rising prevalence of neurovascular diseases, an aging population, increasing adoption of minimally invasive procedures and technological advancements in device design. Additionally, rising innovations in biocompatible coatings, robotic-assisted platforms and advanced imaging systems are helping hospitals and ambulatory surgical centers meet complex procedural needs while improving safety and efficiency.

Top of FormU.S. Neurovascular Intervention Devices Market Report Highlights

• Based on product type, the embolic coils segment dominated the market in 2024, driven by its proven efficacy in treating intracranial aneurysms and strong clinical adoption.
• In terms of technique, neurothrombectomy procedures led the market in 2024 due to widespread use for rapid vessel recanalization in ischemic stroke cases.
• Based on end users, hospitals held the largest share in 2024, supported by specialized neurointervention suites, trained physicians, and advanced imaging infrastructure.
• A few global key market players include Medtronic plc, Stryker Corporation, Penumbra, Q’Apel Medical, Inc., Johnson & Johnson, Terumo Corporation, Abbott Laboratories, Balt USA, Rapid Medical, VESALIO, Acandis GmbH, Inari Medical, and Zeta Surgical.

Polaris Market Research has segmented the market report on the basis of product, technique, end user, and country:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Embolic Coils
• Carotid Stents
• Intracranial Stents
• Neurovascular Thrombectomy
• Embolic Protection Devices
• Flow Diverters Devices
• Intrasaccular Devices
• Liquid Embolic
• Balloons
• Stent Retrievers

By Technique Outlook (Revenue, USD Billion, 2020–2034)

• Neurothrombectomy Procedure
• Cerebral Angiography
• Stenting
• Coiling Procedures
• Flow Disruption

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals
• Ambulatory Surgical Centers
• Other End Users